1 May 2020 in Journal of Ethnopharmacology
19 June 2023 in Biomedicine & Pharmacotherapy
The difficulty and poor prognosis of malignant tumor have always been a difficult problem to be solved. The internal components of solid tumor are complex, including tumor cells, stromal cells and immune cells, which play an important role in tumor proliferation, migration, metastasis and drug resistance. Hence, targeting of only the tumor cells will not likely improve survival. Various studies have reported that tumor cells and endothelial cells have high plasticity, which is reflected in the fact that they can simulate each other's characteristics by endothelial-mesenchymal transition (EndMT) and vasculogenic mimicry (VM). In this paper, this mutual mimicry concept was integrated and reviewed for the first time, and their similarities and implications for tumor development are discussed. At the same time, possible therapeutic methods are proposed to provide new directions and ideas for clinical targeted therapy and immunotherapy of tumor.
27 November 2023 in Journal of Molecular Cell Biology
Splicing of pre-RNA is a key step in regulating eukaryotic gene expression. Most human genes undergo alternative splicing (AS), where the splice sites in a single gene can be selectively paired to produce multiple isoforms, greatly expanding the functional diversity ( Pan et al., 2008; Wang et al., 2008). The regulation of AS plays a critical role in many cellular activities, such as cell differentiation. Therefore, the dysregulation of AS can lead to a variety of diseases, including cancers ( Scotti and Swanson, 2016). Multiple lines of evidence have shown that mutations in several splicing regulatory cis-elements and/or the dysregulation of splicing factors can lead to splicing alterations, which are closely related to biological processes of tumorigenesis and progression, including invasion, apoptosis, proliferation, etc. ( Bonnal et al., 2020; Wang et al., 2020).
9 July 2025 in eLife preprints
Complex diseases often exhibit sex-dimorphism in morbidity and prognosis, many of which are age-related. However, the underlying mechanisms of sex-dimorphic aging remain foggy, with limited studies across multiple tissues. We systematically analyzed ∼17,000 transcriptomes from 35 human tissues to quantitatively evaluate the individual and combined contributions of sex and age to transcriptomic variations. We discovered extensive sex-dimorphisms during aging with distinct patterns of change in gene expression and alternative splicing (AS). Intriguingly, the male-biased age-associated AS events have a stronger association with Alzheimer’s disease, and the female-biased events are often regulated by several sex-biased splicing factors that may be controlled by estrogen receptors. Breakpoint analysis showed that sex-dimorphic aging rates are significantly associated with decline of sex hormones, with males having a larger and earlier transcriptome change. Collectively, this study uncovered an essential role of sex during aging at the molecular and multi-tissue levels, providing insight into sex-dimorphic regulatory patterns.